Skip to main content

Colton discusses NIH's gamble on Alzheimer's in Science

Friday, September 7, 2018

Research funding for Alzheimer's disease and dementia from the National Institutes of Health has more than tripled over the past three years, with a national goal of treating and preventing the condition by 2025. Jocelyn Kaiser discusses the impetus behind these changes as well as their implications for clinical, translational and basic research in the latest issue of Science, speaking to the Duke Neurology Department's Carol Colton, PhD, among others. Read her article here.